Search research articles
Contact Us
Filters
Showing results (71-80 of 133) with videos related to
Page
of 14
Sort By:
American Journal of Clinical Pathology
|
March 21, 2012
Differentiating between Burkitt lymphoma and CD10+ diffuse large B-cell lymphoma: the role of commonly used flow cytometry cell markers and the application of a multiparameter scoring system
Paul McGowan, Nicole Nelles, Jana Wimmer, et al.
Theranostics
|
April 25, 2017
Aptamer Internalization via Endocytosis Inducing S-Phase Arrest and Priming Maver-1 Lymphoma Cells for Cytarabine Chemotherapy
Huan Li, Shuanghui Yang, Ge Yu, et al.
Biomarker Research
|
September 27, 2025
NPC1 as a novel therapeutic target for induction of pyroptosis in cancers
Chuanchao Zhang, Qiang Wang, Pan Su, et al.
Genes
|
April 25, 2019
Tracking Biodistribution of Myeloid-Derived Cells in Murine Models of Breast Cancer
Jun Li, Junhua Mai, Louis Hinkle, et al.
Sensors & Diagnostics
|
March 31, 2025
Lateral flow assay-based detection of nuclear fusion oncoprotein: implications for screening of acute promyelocytic leukemia
Maede Chabi, Binh Vu, Kristen Brosamer, et al.
ACS Sensors
|
August 13, 2019
Rapid Detection of Mycoplasma-Infected Cells by an ssDNA Aptamer Probe
Yanting Liu, Wenqi Jiang, Shuanghui Yang, et al.
Leukemia Research
|
July 18, 2009
Enhanced antimyeloma cytotoxicity by the combination of arsenic trioxide and bortezomib is further potentiated by p38 MAPK inhibition
Jianguo Wen, Yongdong Feng, Wanting Huang, et al.
Journal for Immunotherapy of Cancer
|
January 24, 2024
Development of therapeutic monoclonal antibodies against DKK1 peptide-HLA-A2 complex to treat human cancers
Jianfei Qian, Qiang Wang, Liuling Xiao, et al.
Molecular Cancer Therapeutics
|
November 11, 2010
Luteinizing Hormone-Releasing Hormone (LHRH)-I antagonist cetrorelix inhibits myeloma cell growth in vitro and in vivo
Jianguo Wen, Yongdong Feng, Chad C Bjorklund, et al.
Journal of Hematology & Oncology
|
May 7, 2022
A novel role of lysophosphatidic acid (LPA) in human myeloma resistance to proteasome inhibitors
Pan Su, Liuling Xiao, Lingqun Ye, et al.
Page
of 14
Search research articles
Search
Showing results (71-80 of 133) with videos related to
Sort By:
Page
of 14
American Journal of Clinical Pathology
|
March 21, 2012
Differentiating between Burkitt lymphoma and CD10+ diffuse large B-cell lymphoma: the role of commonly used flow cytometry cell markers and the application of a multiparameter scoring system
Paul McGowan, Nicole Nelles, Jana Wimmer, et al.
Theranostics
|
April 25, 2017
Aptamer Internalization via Endocytosis Inducing S-Phase Arrest and Priming Maver-1 Lymphoma Cells for Cytarabine Chemotherapy
Huan Li, Shuanghui Yang, Ge Yu, et al.
Biomarker Research
|
September 27, 2025
NPC1 as a novel therapeutic target for induction of pyroptosis in cancers
Chuanchao Zhang, Qiang Wang, Pan Su, et al.
Genes
|
April 25, 2019
Tracking Biodistribution of Myeloid-Derived Cells in Murine Models of Breast Cancer
Jun Li, Junhua Mai, Louis Hinkle, et al.
Sensors & Diagnostics
|
March 31, 2025
Lateral flow assay-based detection of nuclear fusion oncoprotein: implications for screening of acute promyelocytic leukemia
Maede Chabi, Binh Vu, Kristen Brosamer, et al.
ACS Sensors
|
August 13, 2019
Rapid Detection of Mycoplasma-Infected Cells by an ssDNA Aptamer Probe
Yanting Liu, Wenqi Jiang, Shuanghui Yang, et al.
Leukemia Research
|
July 18, 2009
Enhanced antimyeloma cytotoxicity by the combination of arsenic trioxide and bortezomib is further potentiated by p38 MAPK inhibition
Jianguo Wen, Yongdong Feng, Wanting Huang, et al.
Journal for Immunotherapy of Cancer
|
January 24, 2024
Development of therapeutic monoclonal antibodies against DKK1 peptide-HLA-A2 complex to treat human cancers
Jianfei Qian, Qiang Wang, Liuling Xiao, et al.
Molecular Cancer Therapeutics
|
November 11, 2010
Luteinizing Hormone-Releasing Hormone (LHRH)-I antagonist cetrorelix inhibits myeloma cell growth in vitro and in vivo
Jianguo Wen, Yongdong Feng, Chad C Bjorklund, et al.
Journal of Hematology & Oncology
|
May 7, 2022
A novel role of lysophosphatidic acid (LPA) in human myeloma resistance to proteasome inhibitors
Pan Su, Liuling Xiao, Lingqun Ye, et al.
Page
of 14